Literature DB >> 16141544

Phosphatidylserine-specific receptor contributes to TGF-beta production in macrophages through a MAP kinase, ERK.

Masaki Otsuka1, Kentaro Goto, Seishi Tsuchiya, Yukihiko Aramaki.   

Abstract

We explored the involvement of the phosphatidylserine (PS)-receptor in the production of TGF-beta by macrophages treated with PS-liposomes. The binding of anti-PS-receptor antibody to macrophages was specifically inhibited by PS-liposomes. The antibody led to an increase in the production of TGF-beta, and also activated ERK, a member of the MAP kinase. But no activations in p38 and JNK were observed. ERK inhibitor, U0126 completely prevented TGF-beta production. On the addition of a TGF-beta neutralizing antibody or U0126, the inhibitory effect of the anti-PS-receptor antibody on macrophage function, nitric oxide production, was restored. These findings suggested that TGF-beta is one of factors produced by PS-liposomes, and the ERK signaling pathway via the PS-receptor is intimately involved in the production of TGF-beta in macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141544     DOI: 10.1248/bpb.28.1707

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

Review 1.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

2.  SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) prevents cardiac remodeling after myocardial infarction through ERK/SMAD signaling pathway.

Authors:  Yong-Gang Lu; He Tan; Qian Ma; Xin-Xin Li; Jia Cui; Xue Zhang; Xue-Lei Liang; Yan-Qing Tie
Journal:  Hum Cell       Date:  2021-01-08       Impact factor: 4.174

3.  Kidney injury molecule-1 protects against Gα12 activation and tissue damage in renal ischemia-reperfusion injury.

Authors:  Ola Z Ismail; Xizhong Zhang; Junjun Wei; Aaron Haig; Bradley M Denker; Rita S Suri; Alp Sener; Lakshman Gunaratnam
Journal:  Am J Pathol       Date:  2015-03-07       Impact factor: 4.307

4.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

5.  Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.

Authors:  Birgit Romberg; Christien Oussoren; Cor J Snel; Wim E Hennink; Gert Storm
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

6.  Anoctamin 6 regulates C2C12 myoblast proliferation.

Authors:  Piming Zhao; Audrey Torcaso; Andrew Mariano; Li Xu; Sadia Mohsin; Lixia Zhao; Renzhi Han
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.